How to Keep Your Lab EKRA Compliant

Although the Eliminating Kickbacks in Recovery Act (EKRA) was first put into effect in 2018, there has been significant uncertainty concerning how the beefed up anti-kickback rule will be applied as the Covid-19 Public Health Emergency winds down. With the DOJ now ramping up enforcement as the country returns to normal, clinical labs should be taking steps to ensure their compensation and marketing arrangements don't run afoul of EKRA, which bars traditional volume- and value-based payment structures for employees.

During this webinar, you will learn:

-An overview of compensation arrangements barred under EKRA, including safe harbor exceptions.

-How the law interacts with and differs from Anti-Kickback Statute.

-Alternative compensation strategies for your sales and marketing employees.